 | • レポートコード：MRC2Q12-02173 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、イミペネム注射APIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にイミペネム注射APIのグローバル市場のxxx％を占める「0.98」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療用医薬品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 イミペネム注射APIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのイミペネム注射API市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 イミペネム注射APIのグローバル主要プレイヤーには、Shenzhen Haibin Pharmaceutical、Zhuhai United Laboratories、Zhejiang Jiuzhou Pharmaceutical、Savior Lifetec Corporation、ACS Dobfar、Sun Pharma、Kaliberr Labs、Jeil Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 イミペネム注射API市場は、種類と用途によって区分されます。世界のイミペネム注射API市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 0.98、0.99、その他 【用途別セグメント】 医療用医薬品、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - イミペネム注射API製品概要 - 種類別市場（0.98、0.99、その他） - 用途別市場（医療用医薬品、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界のイミペネム注射API販売量予測2017-2028 - 世界のイミペネム注射API売上予測2017-2028 - イミペネム注射APIの地域別販売量 - イミペネム注射APIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別イミペネム注射API販売量 - 主要メーカー別イミペネム注射API売上 - 主要メーカー別イミペネム注射API価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（0.98、0.99、その他） - イミペネム注射APIの種類別販売量 - イミペネム注射APIの種類別売上 - イミペネム注射APIの種類別価格 ・用途別市場規模（医療用医薬品、科学研究） - イミペネム注射APIの用途別販売量 - イミペネム注射APIの用途別売上 - イミペネム注射APIの用途別価格 ・北米市場 - 北米のイミペネム注射API市場規模（種類別、用途別） - 主要国別のイミペネム注射API市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのイミペネム注射API市場規模（種類別、用途別） - 主要国別のイミペネム注射API市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のイミペネム注射API市場規模（種類別、用途別） - 主要国別のイミペネム注射API市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のイミペネム注射API市場規模（種類別、用途別） - 主要国別のイミペネム注射API市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのイミペネム注射API市場規模（種類別、用途別） - 主要国別のイミペネム注射API市場規模（トルコ、サウジアラビア） ・企業情報 Shenzhen Haibin Pharmaceutical、Zhuhai United Laboratories、Zhejiang Jiuzhou Pharmaceutical、Savior Lifetec Corporation、ACS Dobfar、Sun Pharma、Kaliberr Labs、Jeil Pharmaceutical ・産業チェーン及び販売チャネル分析 - イミペネム注射APIの産業チェーン分析 - イミペネム注射APIの原材料 - イミペネム注射APIの生産プロセス - イミペネム注射APIの販売及びマーケティング - イミペネム注射APIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - イミペネム注射APIの産業動向 - イミペネム注射APIのマーケットドライバー - イミペネム注射APIの課題 - イミペネム注射APIの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Imipenem Injection API Market
Due to the COVID-19 pandemic, the global Imipenem Injection API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 0.98 accounting for % of the Imipenem Injection API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Imipenem Injection API market size is valued at US$ million in 2021, while the US and Europe Imipenem Injection API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Imipenem Injection API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Imipenem Injection API include Shenzhen Haibin Pharmaceutical, Zhuhai United Laboratories, Zhejiang Jiuzhou Pharmaceutical, Savior Lifetec Corporation, ACS Dobfar, Sun Pharma, Kaliberr Labs and Jeil Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Imipenem Injection API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Imipenem Injection API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Global Imipenem Injection API Scope and Segment
Imipenem Injection API market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global Imipenem Injection API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
0.98
0.99
Others
Segment by Application
Medical Pharmaceutical
Scientific Research
By Company
Shenzhen Haibin Pharmaceutical
Zhuhai United Laboratories
Zhejiang Jiuzhou Pharmaceutical
Savior Lifetec Corporation
ACS Dobfar
Sun Pharma
Kaliberr Labs
Jeil Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Imipenem Injection API Product Introduction
1.2 Market by Purity
1.2.1 Global Imipenem Injection API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Market by Application
1.3.1 Global Imipenem Injection API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Pharmaceutical
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Imipenem Injection API Production
2.1 Global Imipenem Injection API Production Capacity (2017-2028)
2.2 Global Imipenem Injection API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Imipenem Injection API Production by Region
2.3.1 Global Imipenem Injection API Historic Production by Region (2017-2022)
2.3.2 Global Imipenem Injection API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Imipenem Injection API Sales in Volume & Value Estimates and Forecasts
3.1 Global Imipenem Injection API Sales Estimates and Forecasts 2017-2028
3.2 Global Imipenem Injection API Revenue Estimates and Forecasts 2017-2028
3.3 Global Imipenem Injection API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Imipenem Injection API Sales by Region
3.4.1 Global Imipenem Injection API Sales by Region (2017-2022)
3.4.2 Global Sales Imipenem Injection API by Region (2023-2028)
3.5 Global Imipenem Injection API Revenue by Region
3.5.1 Global Imipenem Injection API Revenue by Region (2017-2022)
3.5.2 Global Imipenem Injection API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Imipenem Injection API Production Capacity by Manufacturers
4.2 Global Imipenem Injection API Sales by Manufacturers
4.2.1 Global Imipenem Injection API Sales by Manufacturers (2017-2022)
4.2.2 Global Imipenem Injection API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Imipenem Injection API in 2021
4.3 Global Imipenem Injection API Revenue by Manufacturers
4.3.1 Global Imipenem Injection API Revenue by Manufacturers (2017-2022)
4.3.2 Global Imipenem Injection API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Imipenem Injection API Revenue in 2021
4.4 Global Imipenem Injection API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Imipenem Injection API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Imipenem Injection API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Imipenem Injection API Sales by Purity
5.1.1 Global Imipenem Injection API Historical Sales by Purity (2017-2022)
5.1.2 Global Imipenem Injection API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Imipenem Injection API Sales Market Share by Purity (2017-2028)
5.2 Global Imipenem Injection API Revenue by Purity
5.2.1 Global Imipenem Injection API Historical Revenue by Purity (2017-2022)
5.2.2 Global Imipenem Injection API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Imipenem Injection API Revenue Market Share by Purity (2017-2028)
5.3 Global Imipenem Injection API Price by Purity
5.3.1 Global Imipenem Injection API Price by Purity (2017-2022)
5.3.2 Global Imipenem Injection API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Imipenem Injection API Sales by Application
6.1.1 Global Imipenem Injection API Historical Sales by Application (2017-2022)
6.1.2 Global Imipenem Injection API Forecasted Sales by Application (2023-2028)
6.1.3 Global Imipenem Injection API Sales Market Share by Application (2017-2028)
6.2 Global Imipenem Injection API Revenue by Application
6.2.1 Global Imipenem Injection API Historical Revenue by Application (2017-2022)
6.2.2 Global Imipenem Injection API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Imipenem Injection API Revenue Market Share by Application (2017-2028)
6.3 Global Imipenem Injection API Price by Application
6.3.1 Global Imipenem Injection API Price by Application (2017-2022)
6.3.2 Global Imipenem Injection API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Imipenem Injection API Market Size by Purity
7.1.1 North America Imipenem Injection API Sales by Purity (2017-2028)
7.1.2 North America Imipenem Injection API Revenue by Purity (2017-2028)
7.2 North America Imipenem Injection API Market Size by Application
7.2.1 North America Imipenem Injection API Sales by Application (2017-2028)
7.2.2 North America Imipenem Injection API Revenue by Application (2017-2028)
7.3 North America Imipenem Injection API Sales by Country
7.3.1 North America Imipenem Injection API Sales by Country (2017-2028)
7.3.2 North America Imipenem Injection API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Imipenem Injection API Market Size by Purity
8.1.1 Europe Imipenem Injection API Sales by Purity (2017-2028)
8.1.2 Europe Imipenem Injection API Revenue by Purity (2017-2028)
8.2 Europe Imipenem Injection API Market Size by Application
8.2.1 Europe Imipenem Injection API Sales by Application (2017-2028)
8.2.2 Europe Imipenem Injection API Revenue by Application (2017-2028)
8.3 Europe Imipenem Injection API Sales by Country
8.3.1 Europe Imipenem Injection API Sales by Country (2017-2028)
8.3.2 Europe Imipenem Injection API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Imipenem Injection API Market Size by Purity
9.1.1 Asia Pacific Imipenem Injection API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Imipenem Injection API Revenue by Purity (2017-2028)
9.2 Asia Pacific Imipenem Injection API Market Size by Application
9.2.1 Asia Pacific Imipenem Injection API Sales by Application (2017-2028)
9.2.2 Asia Pacific Imipenem Injection API Revenue by Application (2017-2028)
9.3 Asia Pacific Imipenem Injection API Sales by Region
9.3.1 Asia Pacific Imipenem Injection API Sales by Region (2017-2028)
9.3.2 Asia Pacific Imipenem Injection API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Imipenem Injection API Market Size by Purity
10.1.1 Latin America Imipenem Injection API Sales by Purity (2017-2028)
10.1.2 Latin America Imipenem Injection API Revenue by Purity (2017-2028)
10.2 Latin America Imipenem Injection API Market Size by Application
10.2.1 Latin America Imipenem Injection API Sales by Application (2017-2028)
10.2.2 Latin America Imipenem Injection API Revenue by Application (2017-2028)
10.3 Latin America Imipenem Injection API Sales by Country
10.3.1 Latin America Imipenem Injection API Sales by Country (2017-2028)
10.3.2 Latin America Imipenem Injection API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Imipenem Injection API Market Size by Purity
11.1.1 Middle East and Africa Imipenem Injection API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Imipenem Injection API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Imipenem Injection API Market Size by Application
11.2.1 Middle East and Africa Imipenem Injection API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Imipenem Injection API Revenue by Application (2017-2028)
11.3 Middle East and Africa Imipenem Injection API Sales by Country
11.3.1 Middle East and Africa Imipenem Injection API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Imipenem Injection API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Shenzhen Haibin Pharmaceutical
12.1.1 Shenzhen Haibin Pharmaceutical Corporation Information
12.1.2 Shenzhen Haibin Pharmaceutical Overview
12.1.3 Shenzhen Haibin Pharmaceutical Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Shenzhen Haibin Pharmaceutical Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Shenzhen Haibin Pharmaceutical Recent Developments
12.2 Zhuhai United Laboratories
12.2.1 Zhuhai United Laboratories Corporation Information
12.2.2 Zhuhai United Laboratories Overview
12.2.3 Zhuhai United Laboratories Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Zhuhai United Laboratories Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zhuhai United Laboratories Recent Developments
12.3 Zhejiang Jiuzhou Pharmaceutical
12.3.1 Zhejiang Jiuzhou Pharmaceutical Corporation Information
12.3.2 Zhejiang Jiuzhou Pharmaceutical Overview
12.3.3 Zhejiang Jiuzhou Pharmaceutical Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Zhejiang Jiuzhou Pharmaceutical Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
12.4 Savior Lifetec Corporation
12.4.1 Savior Lifetec Corporation Corporation Information
12.4.2 Savior Lifetec Corporation Overview
12.4.3 Savior Lifetec Corporation Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Savior Lifetec Corporation Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Savior Lifetec Corporation Recent Developments
12.5 ACS Dobfar
12.5.1 ACS Dobfar Corporation Information
12.5.2 ACS Dobfar Overview
12.5.3 ACS Dobfar Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 ACS Dobfar Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 ACS Dobfar Recent Developments
12.6 Sun Pharma
12.6.1 Sun Pharma Corporation Information
12.6.2 Sun Pharma Overview
12.6.3 Sun Pharma Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Sun Pharma Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Sun Pharma Recent Developments
12.7 Kaliberr Labs
12.7.1 Kaliberr Labs Corporation Information
12.7.2 Kaliberr Labs Overview
12.7.3 Kaliberr Labs Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Kaliberr Labs Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Kaliberr Labs Recent Developments
12.8 Jeil Pharmaceutical
12.8.1 Jeil Pharmaceutical Corporation Information
12.8.2 Jeil Pharmaceutical Overview
12.8.3 Jeil Pharmaceutical Imipenem Injection API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Jeil Pharmaceutical Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Jeil Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Imipenem Injection API Industry Chain Analysis
13.2 Imipenem Injection API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Imipenem Injection API Production Mode & Process
13.4 Imipenem Injection API Sales and Marketing
13.4.1 Imipenem Injection API Sales Channels
13.4.2 Imipenem Injection API Distributors
13.5 Imipenem Injection API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Imipenem Injection API Industry Trends
14.2 Imipenem Injection API Market Drivers
14.3 Imipenem Injection API Market Challenges
14.4 Imipenem Injection API Market Restraints
15 Key Finding in The Global Imipenem Injection API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Imipenem Injection API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.98
Table 3. Major Manufacturers of 0.99
Table 4. Major Manufacturers of Others
Table 5. Global Imipenem Injection API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Imipenem Injection API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 7. Global Imipenem Injection API Production by Region (2017-2022) & (Tons)
Table 8. Global Imipenem Injection API Production Market Share by Region (2017-2022)
Table 9. Global Imipenem Injection API Production by Region (2023-2028) & (Tons)
Table 10. Global Imipenem Injection API Production Market Share by Region (2023-2028)
Table 11. Global Imipenem Injection API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Imipenem Injection API Sales by Region (2017-2022) & (Tons)
Table 13. Global Imipenem Injection API Sales Market Share by Region (2017-2022)
Table 14. Global Imipenem Injection API Sales by Region (2023-2028) & (Tons)
Table 15. Global Imipenem Injection API Sales Market Share by Region (2023-2028)
Table 16. Global Imipenem Injection API Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Imipenem Injection API Revenue Market Share by Region (2017-2022)
Table 18. Global Imipenem Injection API Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Imipenem Injection API Revenue Market Share by Region (2023-2028)
Table 20. Global Imipenem Injection API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 21. Global Imipenem Injection API Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Imipenem Injection API Sales by Manufacturers (2017-2022) & (Tons)
Table 23. Global Imipenem Injection API Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Imipenem Injection API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Imipenem Injection API Revenue Share by Manufacturers (2017-2022)
Table 26. Imipenem Injection API Price by Manufacturers 2017-2022 (US$/Kg)
Table 27. Global Imipenem Injection API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Imipenem Injection API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imipenem Injection API as of 2021)
Table 29. Imipenem Injection API Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Imipenem Injection API Product Offered
Table 31. Date of Manufacturers Enter into Imipenem Injection API Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Imipenem Injection API Sales by Purity (2017-2022) & (Tons)
Table 34. Global Imipenem Injection API Sales by Purity (2023-2028) & (Tons)
Table 35. Global Imipenem Injection API Sales Share by Purity (2017-2022)
Table 36. Global Imipenem Injection API Sales Share by Purity (2023-2028)
Table 37. Global Imipenem Injection API Revenue by Purity (2017-2022) & (US$ Million)
Table 38. Global Imipenem Injection API Revenue by Purity (2023-2028) & (US$ Million)
Table 39. Global Imipenem Injection API Revenue Share by Purity (2017-2022)
Table 40. Global Imipenem Injection API Revenue Share by Purity (2023-2028)
Table 41. Imipenem Injection API Price by Purity (2017-2022) & (US$/Kg)
Table 42. Global Imipenem Injection API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 43. Global Imipenem Injection API Sales by Application (2017-2022) & (Tons)
Table 44. Global Imipenem Injection API Sales by Application (2023-2028) & (Tons)
Table 45. Global Imipenem Injection API Sales Share by Application (2017-2022)
Table 46. Global Imipenem Injection API Sales Share by Application (2023-2028)
Table 47. Global Imipenem Injection API Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Imipenem Injection API Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Imipenem Injection API Revenue Share by Application (2017-2022)
Table 50. Global Imipenem Injection API Revenue Share by Application (2023-2028)
Table 51. Imipenem Injection API Price by Application (2017-2022) & (US$/Kg)
Table 52. Global Imipenem Injection API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 53. North America Imipenem Injection API Sales by Purity (2017-2022) & (Tons)
Table 54. North America Imipenem Injection API Sales by Purity (2023-2028) & (Tons)
Table 55. North America Imipenem Injection API Revenue by Purity (2017-2022) & (US$ Million)
Table 56. North America Imipenem Injection API Revenue by Purity (2023-2028) & (US$ Million)
Table 57. North America Imipenem Injection API Sales by Application (2017-2022) & (Tons)
Table 58. North America Imipenem Injection API Sales by Application (2023-2028) & (Tons)
Table 59. North America Imipenem Injection API Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Imipenem Injection API Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Imipenem Injection API Sales by Country (2017-2022) & (Tons)
Table 62. North America Imipenem Injection API Sales by Country (2023-2028) & (Tons)
Table 63. North America Imipenem Injection API Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Imipenem Injection API Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Imipenem Injection API Sales by Purity (2017-2022) & (Tons)
Table 66. Europe Imipenem Injection API Sales by Purity (2023-2028) & (Tons)
Table 67. Europe Imipenem Injection API Revenue by Purity (2017-2022) & (US$ Million)
Table 68. Europe Imipenem Injection API Revenue by Purity (2023-2028) & (US$ Million)
Table 69. Europe Imipenem Injection API Sales by Application (2017-2022) & (Tons)
Table 70. Europe Imipenem Injection API Sales by Application (2023-2028) & (Tons)
Table 71. Europe Imipenem Injection API Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Imipenem Injection API Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Imipenem Injection API Sales by Country (2017-2022) & (Tons)
Table 74. Europe Imipenem Injection API Sales by Country (2023-2028) & (Tons)
Table 75. Europe Imipenem Injection API Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Imipenem Injection API Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Imipenem Injection API Sales by Purity (2017-2022) & (Tons)
Table 78. Asia Pacific Imipenem Injection API Sales by Purity (2023-2028) & (Tons)
Table 79. Asia Pacific Imipenem Injection API Revenue by Purity (2017-2022) & (US$ Million)
Table 80. Asia Pacific Imipenem Injection API Revenue by Purity (2023-2028) & (US$ Million)
Table 81. Asia Pacific Imipenem Injection API Sales by Application (2017-2022) & (Tons)
Table 82. Asia Pacific Imipenem Injection API Sales by Application (2023-2028) & (Tons)
Table 83. Asia Pacific Imipenem Injection API Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Imipenem Injection API Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Imipenem Injection API Sales by Region (2017-2022) & (Tons)
Table 86. Asia Pacific Imipenem Injection API Sales by Region (2023-2028) & (Tons)
Table 87. Asia Pacific Imipenem Injection API Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Imipenem Injection API Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Imipenem Injection API Sales by Purity (2017-2022) & (Tons)
Table 90. Latin America Imipenem Injection API Sales by Purity (2023-2028) & (Tons)
Table 91. Latin America Imipenem Injection API Revenue by Purity (2017-2022) & (US$ Million)
Table 92. Latin America Imipenem Injection API Revenue by Purity (2023-2028) & (US$ Million)
Table 93. Latin America Imipenem Injection API Sales by Application (2017-2022) & (Tons)
Table 94. Latin America Imipenem Injection API Sales by Application (2023-2028) & (Tons)
Table 95. Latin America Imipenem Injection API Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Imipenem Injection API Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Imipenem Injection API Sales by Country (2017-2022) & (Tons)
Table 98. Latin America Imipenem Injection API Sales by Country (2023-2028) & (Tons)
Table 99. Latin America Imipenem Injection API Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Imipenem Injection API Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Imipenem Injection API Sales by Purity (2017-2022) & (Tons)
Table 102. Middle East and Africa Imipenem Injection API Sales by Purity (2023-2028) & (Tons)
Table 103. Middle East and Africa Imipenem Injection API Revenue by Purity (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Imipenem Injection API Revenue by Purity (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Imipenem Injection API Sales by Application (2017-2022) & (Tons)
Table 106. Middle East and Africa Imipenem Injection API Sales by Application (2023-2028) & (Tons)
Table 107. Middle East and Africa Imipenem Injection API Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Imipenem Injection API Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Imipenem Injection API Sales by Country (2017-2022) & (Tons)
Table 110. Middle East and Africa Imipenem Injection API Sales by Country (2023-2028) & (Tons)
Table 111. Middle East and Africa Imipenem Injection API Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Imipenem Injection API Revenue by Country (2023-2028) & (US$ Million)
Table 113. Shenzhen Haibin Pharmaceutical Corporation Information
Table 114. Shenzhen Haibin Pharmaceutical Description and Major Businesses
Table 115. Shenzhen Haibin Pharmaceutical Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 116. Shenzhen Haibin Pharmaceutical Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Shenzhen Haibin Pharmaceutical Recent Development
Table 118. Zhuhai United Laboratories Corporation Information
Table 119. Zhuhai United Laboratories Description and Major Businesses
Table 120. Zhuhai United Laboratories Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 121. Zhuhai United Laboratories Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Zhuhai United Laboratories Recent Development
Table 123. Zhejiang Jiuzhou Pharmaceutical Corporation Information
Table 124. Zhejiang Jiuzhou Pharmaceutical Description and Major Businesses
Table 125. Zhejiang Jiuzhou Pharmaceutical Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 126. Zhejiang Jiuzhou Pharmaceutical Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 128. Savior Lifetec Corporation Corporation Information
Table 129. Savior Lifetec Corporation Description and Major Businesses
Table 130. Savior Lifetec Corporation Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 131. Savior Lifetec Corporation Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Savior Lifetec Corporation Recent Development
Table 133. ACS Dobfar Corporation Information
Table 134. ACS Dobfar Description and Major Businesses
Table 135. ACS Dobfar Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 136. ACS Dobfar Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. ACS Dobfar Recent Development
Table 138. Sun Pharma Corporation Information
Table 139. Sun Pharma Description and Major Businesses
Table 140. Sun Pharma Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 141. Sun Pharma Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sun Pharma Recent Development
Table 143. Kaliberr Labs Corporation Information
Table 144. Kaliberr Labs Description and Major Businesses
Table 145. Kaliberr Labs Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 146. Kaliberr Labs Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Kaliberr Labs Recent Development
Table 148. Jeil Pharmaceutical Corporation Information
Table 149. Jeil Pharmaceutical Description and Major Businesses
Table 150. Jeil Pharmaceutical Imipenem Injection API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 151. Jeil Pharmaceutical Imipenem Injection API Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Jeil Pharmaceutical Recent Development
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Imipenem Injection API Distributors List
Table 156. Imipenem Injection API Customers List
Table 157. Imipenem Injection API Market Trends
Table 158. Imipenem Injection API Market Drivers
Table 159. Imipenem Injection API Market Challenges
Table 160. Imipenem Injection API Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Imipenem Injection API Product Picture
Figure 2. Global Imipenem Injection API Market Share by Purity in 2021 & 2028
Figure 3. 0.98 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Imipenem Injection API Market Share by Application in 2021 & 2028
Figure 7. Medical Pharmaceutical
Figure 8. Scientific Research
Figure 9. Imipenem Injection API Report Years Considered
Figure 10. Global Imipenem Injection API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Imipenem Injection API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Imipenem Injection API Production Market Share by Region (2017-2022)
Figure 13. Global Imipenem Injection API Production Market Share by Region (2023-2028)
Figure 14. Imipenem Injection API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Imipenem Injection API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Imipenem Injection API Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Imipenem Injection API Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 18. Global Imipenem Injection API Sales 2017-2028 (Tons)
Figure 19. Global Imipenem Injection API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Imipenem Injection API Revenue 2017-2028 (US$ Million)
Figure 21. Global Imipenem Injection API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Imipenem Injection API Sales Market Share by Region (2017-2022)
Figure 23. Global Imipenem Injection API Sales Market Share by Region (2023-2028)
Figure 24. North America Imipenem Injection API Sales YoY (2017-2028) & (Tons)
Figure 25. North America Imipenem Injection API Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Imipenem Injection API Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Imipenem Injection API Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Imipenem Injection API Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Imipenem Injection API Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Imipenem Injection API Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Imipenem Injection API Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Imipenem Injection API Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Imipenem Injection API Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Imipenem Injection API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Imipenem Injection API in the World: Market Share by Imipenem Injection API Revenue in 2021
Figure 36. Imipenem Injection API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Imipenem Injection API Sales Market Share by Purity (2017-2028)
Figure 38. Global Imipenem Injection API Revenue Market Share by Purity (2017-2028)
Figure 39. Global Imipenem Injection API Sales Market Share by Application (2017-2028)
Figure 40. Global Imipenem Injection API Revenue Market Share by Application (2017-2028)
Figure 41. North America Imipenem Injection API Sales Market Share by Purity (2017-2028)
Figure 42. North America Imipenem Injection API Revenue Market Share by Purity (2017-2028)
Figure 43. North America Imipenem Injection API Sales Market Share by Application (2017-2028)
Figure 44. North America Imipenem Injection API Revenue Market Share by Application (2017-2028)
Figure 45. North America Imipenem Injection API Sales Share by Country (2017-2028)
Figure 46. North America Imipenem Injection API Revenue Share by Country (2017-2028)
Figure 47. United States Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Imipenem Injection API Sales Market Share by Purity (2017-2028)
Figure 50. Europe Imipenem Injection API Revenue Market Share by Purity (2017-2028)
Figure 51. Europe Imipenem Injection API Sales Market Share by Application (2017-2028)
Figure 52. Europe Imipenem Injection API Revenue Market Share by Application (2017-2028)
Figure 53. Europe Imipenem Injection API Sales Share by Country (2017-2028)
Figure 54. Europe Imipenem Injection API Revenue Share by Country (2017-2028)
Figure 55. Germany Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 56. France Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Imipenem Injection API Sales Market Share by Purity (2017-2028)
Figure 61. Asia Pacific Imipenem Injection API Revenue Market Share by Purity (2017-2028)
Figure 62. Asia Pacific Imipenem Injection API Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Imipenem Injection API Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Imipenem Injection API Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Imipenem Injection API Revenue Share by Region (2017-2028)
Figure 66. China Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 69. India Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Imipenem Injection API Sales Market Share by Purity (2017-2028)
Figure 76. Latin America Imipenem Injection API Revenue Market Share by Purity (2017-2028)
Figure 77. Latin America Imipenem Injection API Sales Market Share by Application (2017-2028)
Figure 78. Latin America Imipenem Injection API Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Imipenem Injection API Sales Share by Country (2017-2028)
Figure 80. Latin America Imipenem Injection API Revenue Share by Country (2017-2028)
Figure 81. Mexico Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Imipenem Injection API Sales Market Share by Purity (2017-2028)
Figure 85. Middle East and Africa Imipenem Injection API Revenue Market Share by Purity (2017-2028)
Figure 86. Middle East and Africa Imipenem Injection API Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Imipenem Injection API Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Imipenem Injection API Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Imipenem Injection API Revenue Share by Country (2017-2028)
Figure 90. Turkey Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Imipenem Injection API Revenue (2017-2028) & (US$ Million)
Figure 93. Imipenem Injection API Value Chain
Figure 94. Imipenem Injection API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed